Operational characteristics of full random effects modelling (‘frem’) compared to stepwise covariate modelling (‘scm’)

Author:

Amann Lisa F.,Wicha Sebastian G.

Abstract

AbstractAn adequate covariate selection is a key step in population pharmacokinetic modelling. In this study, the automated stepwise covariate modelling technique (‘scm’) was compared to full random effects modelling (‘frem’). We evaluated the power to identify a ‘true’ covariate (covariate with highest correlation to the pharmacokinetic parameter), precision, and accuracy of the parameter-covariate estimates. Furthermore, the predictive performance of the final models was assessed. The scenarios varied in covariate effect sizes, number of individuals (n = 20–500) and covariate correlations (0–90% cov-corr). The PsN ‘frem’ routine provides a 90% confidence intervals around the covariate effects. This was used to evaluate its operational characteristics for a statistical backward elimination procedure, defined as ‘fremposthoc’ and to facilitate the comparison to ‘scm’. ‘Fremposthoc’ had a higher power to detect the true covariate with lower bias in small n studies compared to ‘scm’, applied with commonly used settings (forward p < 0.05, backward p < 0.01). This finding was vice versa in a statistically similar setting. For ‘fremposthoc’, power, precision and accuracy of the covariate coefficient increased with higher number of individuals and covariate effect magnitudes. Without a backward elimination step ‘frem’ models provided unbiased coefficients with highly imprecise coefficients in small n datasets. Yet, precision was superior to final ‘scm’ model precision obtained using common settings. We conclude that ‘fremposthoc’ is also a suitable method to guide covariate selection, although intended to serve as a full model approach. However, a deliberated selection of automated methods is essential for the modeller and using those methods in small datasets needs to be taken with caution.

Funder

Universität Hamburg

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology

Reference20 articles.

1. U.S. Food and Drug Administration. Guidance for industry: Pharmacokinetics in patients with impaired hepatic function: Study design, data analysis, and impact on dosing and labeling, U.S.Department of Health and Human Services Food and Drug Administration Center for Drug Evaluation and Research (CDER),Center for Biologics Evaluation and Research (CBER), May 2003.Clinical Pharmacology. Available from http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/ucm072123.pdf. Accessed 23 Jun 2022

2. Gastonguay MR. Full covariate models as an alternative tomethods relying on statistical significance for inferences aboutcovariate effects: a review of methodology and 42 case studies. Twentieth Meeting, Population Approach Group in Europe; 2011 Jun 7–10; Athens. Available at https://www.page-meeting.org/pdf_assets/1694-GastonguayPAGE2011.pdf. Accessed 06 Jan 2023

3. Jonsson EN, Karlsson MO (1998) Automated covariate model building within NONMEM. Pharm Res 15:1463–1468. https://doi.org/10.1023/a:1011970125687

4. Ribbing J, Nyberg J, Caster O, Jonsson EN (2007) The lasso—a novel method for predictive covariate model building in nonlinear mixed effects models. J Pharmacokinet Pharmacodyn 34:485–517. https://doi.org/10.1007/s10928-007-9057-1

5. Wahlby U, Jonsson EN, Karlsson MO (2002) Comparison of stepwise covariate model building strategies in population pharmacokinetic-pharmacodynamic analysis. AAPS PharmSci 4:1–12. https://doi.org/10.1208/ps040427

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3